Plus   Neg

ANI Pharmaceuticals, Inc. Q4 Profit Advances

ANI Pharmaceuticals, Inc. (ANIP) released earnings for its fourth quarter that increased compared to the same period last year.

The company said its bottom line rose to $12.62 million, or $1.08 per share. This was up from $10.52 million, or $0.90 per share, in last year's fourth quarter.

The company said revenue for the quarter rose 23.8% to $47.29 million. This was up from $38.21 million last year.

ANI Pharmaceuticals, Inc. earnings at a glance:

-Earnings (Q4): $12.62 Mln. vs. $10.52 Mln. last year.
-Earnings Growth (Y-o-Y): 20.0%
-EPS (Q4): $1.08 vs. $0.90 last year.
-EPS Growth (Y-o-Y): 20.0%
-Revenue (Q4): $47.29 Mln vs. $38.21 Mln last year.
-Revenue Change (Y-o-Y): 23.8%

Full year EPS guidance: $5.43 to $6.08
Full year revenue guidance: $212 - $228 Mln

For comments and feedback contact: editorial@rttnews.com

Follow RTT